Xiao et al. reported decreased OS and response to immunotherapy in colon cancer patients with significantly decreased Fas expression [27], while Shibakita et al. demonstrated that Fas expression was an independent negative prognostic factor for RFS in patients with esophageal cancer [28]. The gene discussed is FAS; the disease is colonic neoplasm.